Is multidisciplinary treatment effective for invasive intraductal papillary mucinous carcinoma?
Seiko HironoRyota HiguchiGoro HondaSatoshi NaraMinoru EsakiNaoto GotohdaHideki TakamiMichiaki UnnoTeiichi SugiuraMasayuki OhtsukaYasuhiro ShimizuIppei MatsumotoToshifumi KinHiroyuki IsayamaDaisuke HashimotoYasuji SeyamaHiroaki NaganoKenichi HakamadaSatoshi HiranoYuichi NagakawaHiroyuki SakuraiHidenori TakahashiKazuto ShibuyaHideki SasanumaTaku AokiYuichiro KoharaToshiki RikiyamaMasafumi NakamuraItraru EndoYoshihiro SakamotoAkihiko HoriguchiTakashi HatoriHirofumi AkitaToshiharu UekiTetsuya IdichiKeiji HanadaShuji SuzukiKeiichi OkanoHiromitsu MaehiraFuyuhiko MotoiYasuhiro FujinoSatoshi TannoAkio YanagisawaYoshifumi TakeyamaKazuichi OkazakiSohei SatoiHiroki YamauePublished in: Annals of gastroenterological surgery (2024)
Postoperative AT might benefit selected patients with invasive IPMC, especially those at high risk of poor survival. NAT might improve the survivability of BR invasive IPMC. Any treatment for recurrence after surgery for invasive IPMC might improve survival.